Since the outbreak in last December of the novel severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in Wuhan, China, scientific literature is providing essential contributions to elucidate the pathophysiological and clinical features of the Coronavirus disease 2019 (COVID‐19).(1) Consistent evidence shows that COVID‐19 is associated with significant changes in coagulation laboratory testing, mainly prolonged prothrombin time and elevated D‐dimer.(2)